ANALYSIS: Questions over Abano's Australian operations as sales slump continues

ANALYSIS: Questions over Abano's Australian operations as sales slump continues
Jenny Ruth
By Jenny Ruth July 31 (BusinessDesk) - Abano Healthcare continues to do it tough in Australia where, even though it’s the second-largest corporate player, it has less than 2 percent of the market. Its annual sales across the Tasman haven’t grown since 2012 and appear to be getting worse; a 1.6 percent fall in same-store sales in the nine months ended February turned into a 2.9 percent decline for the year ended May. Abano has acknowledged some of that rot is permanent because it wrote off $2.6 million in goodwill relating to four of it...

More Opinion

Is innovation a priority for National?
Opinion

Peter Griffin: Is innovation a priority for National?

The challenge for Shane Reti will be to chart a new course in science and innovation.

Reflections on NZ's cleantech
Opinion

Phil Anderson: Reflections on NZ's cleantech

Building a NZ cleantech company from scratch starts with being there.

Phil Anderson 22 Jan 2025
First there was Word, then came inflation
Finance

David Chaplin: First there was Word, then came inflation

The Reserve Bank thinks it has tamed the beast – but costs are still rising. 

David Chaplin 22 Jan 2025
The cost of climate inaction
Opinion

Dileepa Fonseka: The cost of climate inaction

Doing nothing will likely cost NZ more than taking action ever will.

Dileepa Fonseka 20 Jan 2025